BCa tumors are classified into distinct subtypes (Luminal A, Luminal B, HER2+, and TNBC), characterized by expression levels of estrogen and progesterone receptors, and HER2 expression in tumor cells. This evidence concerns the gene ERBB2 and neoplasm.